![[Article / IP Generally] Notes on the prohibition of abuse of rights in intellectual property infringement (Teruo Morimoto, Patent, December 2025)](https://static.wixstatic.com/media/324a18_37a5f1ba493f4e0d9428363401e9350a~mv2.png/v1/fill/w_332,h_250,fp_0.50_0.50,q_35,blur_30,enc_avif,quality_auto/324a18_37a5f1ba493f4e0d9428363401e9350a~mv2.webp)
![[Article / IP Generally] Notes on the prohibition of abuse of rights in intellectual property infringement (Teruo Morimoto, Patent, December 2025)](https://static.wixstatic.com/media/324a18_37a5f1ba493f4e0d9428363401e9350a~mv2.png/v1/fill/w_319,h_240,fp_0.50_0.50,q_95,enc_avif,quality_auto/324a18_37a5f1ba493f4e0d9428363401e9350a~mv2.webp)
[Article / IP Generally] Notes on the prohibition of abuse of rights in intellectual property infringement (Teruo Morimoto, Patent, December 2025)
① The Ricoh case and how “compulsory mediation” should operate Although the first-instance judgment also dismissed damages entirely, as long as the implementer actually enjoys the patented invention's benefits, a solution denying an injunction but allowing payment equivalent to a reasonable licence fee (royalty)—following the Supreme Court's 1968 judgment—is desirable from the perspectives of legal consistency and equity.
![[Article / Patents] Research and proposals on lack of unity in inventions expressed as alternatives (Biotechnology and Life Sciences Committee, Patent, December 2025)](https://static.wixstatic.com/media/324a18_742a953c06044eb5b4ed91a51244837a~mv2.png/v1/fill/w_332,h_250,fp_0.50_0.50,q_35,blur_30,enc_avif,quality_auto/324a18_742a953c06044eb5b4ed91a51244837a~mv2.webp)
![[Article / Patents] Research and proposals on lack of unity in inventions expressed as alternatives (Biotechnology and Life Sciences Committee, Patent, December 2025)](https://static.wixstatic.com/media/324a18_742a953c06044eb5b4ed91a51244837a~mv2.png/v1/fill/w_319,h_240,fp_0.50_0.50,q_95,enc_avif,quality_auto/324a18_742a953c06044eb5b4ed91a51244837a~mv2.webp)
[Article / Patents] Research and proposals on lack of unity in inventions expressed as alternatives (Biotechnology and Life Sciences Committee, Patent, December 2025)
1. The Japan Patent Office's (JPO) “first alternative” principle In chemistry and biotechnology, compounds and sequences are commonly expressed as alternatives (Markush form), such as “R is A, B or C” or “any of SEQ ID NOs. 1–4.” Under Japan's Examination Guidelines, the first-listed alternative is, in principle, selected for examination when assessing unity (Patent Act Article 37).
[Article / Agriculture and Fisheries] Protecting and using intellectual property through an IP mix with overseas expansion in view (Agriculture and Fisheries Committee, Patent, January 2026)
1. Branding by vegetable producers Separate breeders' rights from trademarks: Registered variety names enter the public domain after the protection term, so obtain trademark rights too. For brands closely linked to a region, strategically distinguish between the GI and regional collective trademark systems.
![[Article / Designs] Overview of court decisions on employee-created designs (Tsuyoshi Fujimoto, Patent, January 2026)](https://static.wixstatic.com/media/324a18_ad141ac4a02b45d2bf0cd7a35874b87b~mv2.png/v1/fill/w_332,h_250,fp_0.50_0.50,q_35,blur_30,enc_avif,quality_auto/324a18_ad141ac4a02b45d2bf0cd7a35874b87b~mv2.webp)
![[Article / Designs] Overview of court decisions on employee-created designs (Tsuyoshi Fujimoto, Patent, January 2026)](https://static.wixstatic.com/media/324a18_ad141ac4a02b45d2bf0cd7a35874b87b~mv2.png/v1/fill/w_319,h_240,fp_0.50_0.50,q_95,enc_avif,quality_auto/324a18_ad141ac4a02b45d2bf0cd7a35874b87b~mv2.webp)
[Article / Designs] Overview of court decisions on employee-created designs (Tsuyoshi Fujimoto, Patent, January 2026)
There have been five cases claiming remuneration solely on the basis of employee-created designs, but no published court decision has awarded it. Compared with patents (employee inventions), the following differences and points warrant attention in calculating reasonable remuneration.
![[Article / Patents] Cases and challenges in patent protection for biopharmaceuticals (Biotechnology and Life Sciences Committee, Patent, December 2025)](https://static.wixstatic.com/media/324a18_cf7da5b8b6a24d4288bdcfb41718dc88~mv2.png/v1/fill/w_332,h_250,fp_0.50_0.50,q_35,blur_30,enc_avif,quality_auto/324a18_cf7da5b8b6a24d4288bdcfb41718dc88~mv2.webp)
![[Article / Patents] Cases and challenges in patent protection for biopharmaceuticals (Biotechnology and Life Sciences Committee, Patent, December 2025)](https://static.wixstatic.com/media/324a18_cf7da5b8b6a24d4288bdcfb41718dc88~mv2.png/v1/fill/w_319,h_240,fp_0.50_0.50,q_95,enc_avif,quality_auto/324a18_cf7da5b8b6a24d4288bdcfb41718dc88~mv2.webp)
[Article / Patents] Cases and challenges in patent protection for biopharmaceuticals (Biotechnology and Life Sciences Committee, Patent, December 2025)
1. De facto patent linkage in Japan Under the practice based on the Ministry of Health, Labour and Welfare's “two division directors' notification,” biosimilars (BS) are, in principle, not approved while patents exist on the originator product's active ingredient or use. 2. Re-examination period
[Article / Patents] Points to note when filing food-use inventions in different countries (Biotechnology and Life Sciences Committee, Patent, December 2025)
In Japan, the 2016 revision of the Examination Guidelines strengthened protection for food-use inventions, but overseas, national laws and examination practices differ greatly. 1. Permissible claims ① US: Product-use inventions are not recognized; draft as methods. A use in the preamble often has no limiting effect.
Consultation options: find the right starting point
Five starting points for enquiries: warning letters, enforcement, patent validity, intellectual property contracts, and training or lectures.
Topic guide: Claim interpretation and equivalents
Explore articles on claim interpretation, the doctrine of equivalents and product-by-process claims. Consult the individual articles and their sources for the facts and discussion of each case.
Topic guide: AI and intellectual property
Explore existing articles on AI and intellectual property, including rights relating to voice and IP strategy in the AI era.
Topic guide: Inventive step
Explore existing articles on inventive step, design choices, motivation and teaching away. The collection includes case notes, reviews of publications and lecture materials. See each article for its discussion and sources.